Stock Screener
Stock Research
Delisted Stocks
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Vertex Pharmaceuticals SG&A Expenses 2010-2024 | VRTX

Vertex Pharmaceuticals annual/quarterly sg&a expenses history and growth rate from 2010 to 2024. Sg&a expenses can be defined as the sum of all selling, general and administrative expenses.
  • Vertex Pharmaceuticals sg&a expenses for the quarter ending March 31, 2024 were $0.343B, a 42.14% increase year-over-year.
  • Vertex Pharmaceuticals sg&a expenses for the twelve months ending March 31, 2024 were $1.238B, a 27.57% increase year-over-year.
  • Vertex Pharmaceuticals annual sg&a expenses for 2023 were $1.137B, a 20.31% increase from 2022.
  • Vertex Pharmaceuticals annual sg&a expenses for 2022 were $0.945B, a 12.45% increase from 2021.
  • Vertex Pharmaceuticals annual sg&a expenses for 2021 were $0.84B, a 9.03% increase from 2020.
  
Vertex Pharmaceuticals Annual SG&A Expenses
(Millions of US $)
2023 $1,137
2022 $945
2021 $840
2020 $771
2019 $659
2018 $558
2017 $496
2016 $433
2015 $377
2014 $305
2013 $356
2012 $433
2011 $401
2010 $188
2009 $130
Vertex Pharmaceuticals Quarterly SG&A Expenses
(Millions of US $)
2024-03-31 $343
2023-12-31 $369
2023-09-30 $264
2023-06-30 $263
2023-03-31 $241
2022-12-31 $267
2022-09-30 $247
2022-06-30 $215
2022-03-31 $215
2021-12-31 $255
2021-09-30 $198
2021-06-30 $195
2021-03-31 $192
2020-12-31 $212
2020-09-30 $185
2020-06-30 $192
2020-03-31 $182
2019-12-31 $195
2019-09-30 $160
2019-06-30 $157
2019-03-31 $147
2018-12-31 $153
2018-09-30 $137
2018-06-30 $137
2018-03-31 $130
2017-12-31 $135
2017-09-30 $121
2017-06-30 $127
2017-03-31 $113
2016-12-31 $110
2016-09-30 $106
2016-06-30 $112
2016-03-31 $105
2015-12-31 $97
2015-09-30 $100
2015-06-30 $94
2015-03-31 $86
2014-12-31 $79
2014-09-30 $75
2014-06-30 $77
2014-03-31 $74
2013-12-31 $70
2013-09-30 $86
2013-06-30 $107
2013-03-31 $93
2012-12-31 $106
2012-09-30 $98
2012-06-30 $118
2012-03-31 $111
2011-12-31 $122
2011-09-30 $111
2011-06-30 $97
2011-03-31 $72
2010-12-31 $62
2010-09-30 $49
2010-06-30 $41
2010-03-31 $36
2009-12-31 $33
2009-09-30 $37
2009-06-30 $33
2009-03-31 $29
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $113.835B $9.869B
Vertex Pharmaceuticals Incorporated is focused on the discovery, development, and commercialization of small molecule drugs targeting serious diseases. The company's main area of focus is cystic fibrosis. The company's lead marketed products are Trikafta, Symdeko/Symkevi, Orkambi and Kalydeco, which are collectively approved to treat the people with CF in North America, Europe and Australia. Trikafta, Vertex's triple combination regimen, was approved by the FDA for the treatment of CF in people aged 12 years and older who have at least one F508del mutation. While CF remains the main area of focus, Vertex is also developing treatments for sickle cell disease, beta thalassemia, APOL1-mediated kidney disease, type 1 diabetes, pain, alpha-1 antitrypsin deficiency and muscular dystrophies. Pimodivir/VX-787, for the treatment of influenza, was out-licensed to Janssen while oncology candidates VX-970, VX-984 and VX-803 were divested to Merck KGaA.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $158.983B 15.91
Regeneron Pharmaceuticals (REGN) United States $106.493B 26.04
GSK (GSK) United Kingdom $91.768B 10.96
CSL (CSLLY) Australia $88.542B 0.00
Bristol Myers Squibb (BMY) United States $81.591B 38.33
Gilead Sciences (GILD) United States $79.112B 15.76
Moderna (MRNA) United States $56.689B 0.00
Biogen (BIIB) United States $31.217B 14.29
Argenex SE (ARGX) Netherlands $22.451B 0.00
BioNTech SE (BNTX) Germany $22.163B 186.46
Alnylam Pharmaceuticals (ALNY) United States $18.585B 0.00
Genmab (GMAB) Denmark $18.508B 21.70
Illumina (ILMN) United States $16.210B 115.64
BeiGene (BGNE) Cayman Islands $14.476B 0.00
BioMarin Pharmaceutical (BMRN) United States $14.252B 55.60
Incyte (INCY) United States $12.781B 19.76
Bio-Techne Corp (TECH) United States $12.386B 46.79
Sarepta Therapeutics (SRPT) United States $10.988B 968.75
QIAGEN (QGEN) Netherlands $9.717B 20.76
Roivant Sciences (ROIV) United Kingdom $8.647B 0.00
Repligen (RGEN) United States $8.496B 110.99
Exact Sciences (EXAS) United States $8.271B 0.00
Bio-Rad Laboratories (BIO.B) United States $7.984B 26.11
Insmed (INSM) United States $7.958B 0.00
Ascendis Pharma (ASND) Denmark $7.715B 0.00
Legend Biotech (LEGN) United States $7.670B 0.00
Vaxcyte (PCVX) United States $7.389B 0.00
Viking Therapeutics (VKTX) United States $7.036B 0.00
Intra-Cellular Therapies (ITCI) United States $7.025B 0.00
Blueprint Medicines (BPMC) United States $6.297B 0.00
Exelixis (EXEL) United States $6.213B 32.02
Halozyme Therapeutics (HALO) United States $5.442B 15.11
Cytokinetics (CYTK) United States $5.018B 0.00
Apellis Pharmaceuticals (APLS) United States $4.989B 0.00
Zealand Pharma (ZLDPF) Denmark $4.606B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $4.573B 0.00
Krystal Biotech (KRYS) United States $4.465B 0.00
ImmunityBio (IBRX) United States $4.440B 0.00
Immunovant (IMVT) United States $4.296B 0.00
Nuvalent (NUVL) United States $4.263B 0.00
Alkermes (ALKS) Ireland $3.941B 15.42
Axsome Therapeutics (AXSM) United States $3.572B 0.00
HUTCHMED (China) (HCM) Hong Kong, SAR China $3.252B 0.00
Guardant Health (GH) United States $3.193B 0.00
Ultragenyx Pharmaceutical (RARE) United States $3.171B 0.00
Merus (MRUS) Netherlands $3.169B 0.00
SpringWorks Therapeutics (SWTX) United States $3.027B 0.00
Biohaven (BHVN) United States $2.929B 0.00
Xenon Pharmaceuticals (XENE) Canada $2.890B 0.00
Amicus Therapeutics (FOLD) United States $2.772B 0.00
MorphoSys AG (MOR) Germany $2.768B 0.00
IDEAYA Biosciences (IDYA) United States $2.718B 0.00
Arcellx (ACLX) United States $2.699B 0.00
Certara (CERT) United States $2.652B 61.07
Apogee Therapeutics (APGE) United States $2.641B 0.00
MoonLake Immunotherapeutics (MLTX) Switzerland $2.624B 0.00
Iovance Biotherapeutics (IOVA) United States $2.597B 0.00
Denali Therapeutics (DNLI) United States $2.573B 0.00
Avidity Biosciences (RNA) United States $2.545B 0.00
Janux Therapeutics (JANX) United States $2.468B 0.00
ACADIA Pharmaceuticals (ACAD) United States $2.416B 0.00
Twist Bioscience (TWST) United States $2.369B 0.00
Arvinas (ARVN) United States $2.320B 0.00
Immunocore Holdings (IMCR) United Kingdom $2.286B 0.00
Vericel (VCEL) United States $2.272B 0.00
Celldex Therapeutics (CLDX) United States $2.255B 0.00
Fortrea Holdings (FTRE) United States $2.209B 27.15
Deciphera Pharmaceuticals (DCPH) United States $2.206B 0.00
ADMA Biologics Inc (ADMA) United States $2.179B 85.46
CG Oncology (CGON) United States $2.159B 0.00
Rhythm Pharmaceuticals (RYTM) United States $2.159B 0.00
Novavax (NVAX) United States $2.122B 0.00
Intellia Therapeutics (NTLA) United States $2.091B 0.00
Myriad Genetics (MYGN) United States $2.055B 0.00
Vera Therapeutics (VERA) United States $2.031B 0.00
Kymera Therapeutics (KYMR) United States $1.994B 0.00
Bavarian Nordic (BVNRY) Denmark $1.976B 8.61
Geron (GERN) United States $1.969B 0.00
Beam Therapeutics (BEAM) United States $1.949B 0.00
Rocket Pharmaceuticals (RCKT) United States $1.876B 0.00
Inhibrx (INBX) United States $1.787B 0.00
Zai Lab (ZLAB) China $1.782B 0.00
Galapagos (GLPG) Belgium $1.775B 0.00
NeoGenomics (NEO) United States $1.766B 0.00
Sana Biotechnology (SANA) United States $1.717B 0.00
Structure Therapeutics (GPCR) United States $1.689B 0.00
Keros Therapeutics (KROS) United States $1.686B 0.00
Syndax Pharmaceuticals (SNDX) United States $1.676B 0.00
Harmony Biosciences Holdings (HRMY) United States $1.666B 12.70
Protagonist Therapeutics (PTGX) United States $1.635B 11.42
Edgewise Therapeutics (EWTX) United States $1.606B 0.00
Kura Oncology (KURA) United States $1.559B 0.00
Ligand Pharmaceuticals (LGND) United States $1.529B 24.99
Neumora Therapeutics (NMRA) United States $1.517B 0.00
Dynavax Technologies (DVAX) United States $1.509B 192.17
Morphic Holding (MORF) United States $1.508B 0.00
Belite Bio (BLTE) United States $1.424B 0.00
Arcus Biosciences (RCUS) United States $1.378B 0.00
Vir Biotechnology (VIR) United States $1.374B 0.00
Kiniksa Pharmaceuticals (KNSA) Bermuda $1.324B 0.00
ANI Pharmaceuticals (ANIP) United States $1.323B 16.43
Tarsus Pharmaceuticals (TARS) United States $1.311B 0.00
Cullinan Therapeutics (CGEM) United States $1.307B 0.00
Spyre Therapeutics (SYRE) United States $1.291B 0.00
Akero Therapeutics (AKRO) United States $1.290B 0.00
Ginkgo Bioworks Holdings (DNA) United States $1.240B 0.00
MannKind (MNKD) United States $1.234B 151.00
Day One Biopharmaceuticals (DAWN) United States $1.202B 0.00
AbCellera Biologics (ABCL) Canada $1.200B 0.00
Mirum Pharmaceuticals (MIRM) United States $1.141B 0.00
Autolus Therapeutics (AUTL) United Kingdom $1.069B 0.00
Prothena (PRTA) Ireland $1.058B 0.00
MiMedx (MDXG) United States $1.055B 44.69
Arcutis Biotherapeutics (ARQT) United States $0.994B 0.00
Arcturus Therapeutics Holdings (ARCT) United States $0.989B 0.00
Immatics (IMTX) Germany $0.978B 0.00
Verona Pharma American Depositary Share (VRNA) United Kingdom $0.958B 0.00
Liquidia Technologies (LQDA) United States $0.949B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.935B 0.00
Humacyte (HUMA) United States $0.918B 0.00
Mesoblast (MESO) Australia $0.916B 0.00
Immunome (IMNM) United States $0.877B 0.00
Gyre Therapeutics (GYRE) United States $0.851B 0.00
CureVac (CVAC) Germany $0.849B 0.00
Disc Medicine (IRON) United States $0.844B 0.00
Tyra Biosciences (TYRA) United States $0.837B 0.00
Abivax SA (ABVX) France $0.826B 0.00
Zentalis Pharmaceuticals (ZNTL) United States $0.825B 0.00
PureTech Health (PRTC) United States $0.791B 0.00
89BIO (ETNB) United States $0.789B 0.00
Praxis Precision Medicines (PRAX) United States $0.789B 0.00
Prime Medicine (PRME) United States $0.785B 0.00
Viridian Therapeutics (VRDN) United States $0.765B 0.00
Pliant Therapeutics (PLRX) United States $0.761B 0.00
Cytek Biosciences (CTKB) United States $0.756B 0.00
Nurix Therapeutics (NRIX) United States $0.743B 0.00
Cogent Biosciences (COGT) United States $0.737B 0.00
WAVE Life Sciences (WVE) Singapore $0.735B 0.00
Scholar Rock Holding (SRRK) United States $0.735B 0.00
Nuvation Bio (NUVB) United States $0.722B 0.00
Tango Therapeutics (TNGX) United States $0.721B 0.00
Stoke Therapeutics (STOK) United States $0.718B 0.00
CARGO Therapeutics (CRGX) United States $0.710B 0.00
Longboard Pharmaceuticals (LBPH) United States $0.708B 0.00
REGENXBIO (RGNX) United States $0.695B 0.00
Castle Biosciences (CSTL) United States $0.677B 0.00
GH Research (GHRS) Ireland $0.673B 0.00
Dianthus Therapeutics (DNTH) United States $0.650B 0.00
Sinovac Biotech (SVA) China $0.645B 0.00
AnaptysBio (ANAB) United States $0.641B 0.00
Arbutus Biopharma (ABUS) United States $0.634B 0.00
ArriVent BioPharma (AVBP) United States $0.629B 0.00
HilleVax (HLVX) United States $0.628B 0.00
ITeos Therapeutics (ITOS) United States $0.626B 0.00
Mind Medicine (MindMed) (MNMD) United States $0.626B 0.00
Pharming Group (PHAR) Netherlands $0.625B 0.00
Pharming Group (PHGUF) Netherlands $0.622B 0.00
Mineralys Therapeutics (MLYS) United States $0.611B 0.00
Zymeworks (ZYME) United States $0.600B 0.00
Phathom Pharmaceuticals (PHAT) United States $0.590B 0.00
ALX Oncology Holdings (ALXO) United States $0.583B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.571B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.571B 0.00
Oric Pharmaceuticals (ORIC) United States $0.570B 0.00
EnGene Holdings (ENGN) United States $0.555B 0.00
Kyverna Therapeutics (KYTX) United States $0.553B 0.00
Third Harmonic Bio (THRD) United States $0.550B 0.00
Northwest Biotherapeutics (NWBO) United States $0.545B 0.00
Olema Pharmaceuticals (OLMA) United States $0.540B 0.00
Y-mAbs Therapeutics (YMAB) United States $0.538B 0.00
IGM Biosciences (IGMS) United States $0.537B 0.00
PepGen (PEPG) United States $0.537B 0.00
Adaptive Biotechnologies (ADPT) United States $0.528B 0.00
Travere Therapeutics (TVTX) United States $0.521B 0.00
Entrada Therapeutics (TRDA) United States $0.520B 24.43
Avid Bioservices (CDMO) United States $0.506B 0.00
Astria Therapeutics (ATXS) United States $0.493B 0.00
Aerovate Therapeutics (AVTE) United States $0.490B 0.00
MaxCyte (MXCT) United States $0.489B 0.00
Cabaletta Bio (CABA) United States $0.485B 0.00
Oculis Holding AG (OCS) Switzerland $0.483B 0.00
Fulcrum Therapeutics (FULC) United States $0.483B 0.00
Alector (ALEC) United States $0.482B 0.00
Applied Therapeutics (APLT) United States $0.476B 0.00
MEREO BIOPHARMA (MREO) United Kingdom $0.475B 0.00
Absci (ABSI) United States $0.473B 0.00
Celcuity (CELC) United States $0.463B 0.00
Terns Pharmaceuticals (TERN) United States $0.437B 0.00
Annexon (ANNX) United States $0.434B 0.00
Neurogene (NGNE) United States $0.433B 0.00
TScan Therapeutics (TCRX) United States $0.432B 0.00
Voyager Therapeutics (VYGR) United States $0.425B 0.00
FibroBiologics (FBLG) United States $0.424B 0.00
Oxford BioMedica (OXBDF) United Kingdom $0.424B 0.00
Ocugen (OCGN) United States $0.419B 0.00
Editas Medicine (EDIT) United States $0.419B 0.00
Erasca (ERAS) United States $0.418B 0.00
ACELYRIN, INC (SLRN) United States $0.404B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.404B 0.00
Allogene Therapeutics (ALLO) United States $0.398B 0.00
Contineum Therapeutics (CTNM) United States $0.395B 0.00
Biomea Fusion (BMEA) United States $0.391B 0.00
Fate Therapeutics (FATE) United States $0.390B 0.00
Anika Therapeutics (ANIK) United States $0.380B 320.50
Aura Biosciences (AURA) United States $0.372B 0.00
Jasper Therapeutics (JSPR) United States $0.365B 0.00
AC Immune (ACIU) Switzerland $0.363B 0.00
Sutro Biopharma (STRO) United States $0.348B 0.00
Ventyx Biosciences (VTYX) United States $0.348B 0.00
Amarin (AMRN) Ireland $0.345B 0.00
Shattuck Labs (STTK) United States $0.344B 0.00
C4 Therapeutics (CCCC) United States $0.343B 0.00
Alto Neuroscience (ANRO) United States $0.337B 0.00
Skye Bioscience (SKYE) United States $0.337B 0.00
Q32 Bio (QTTB) United States $0.334B 0.00
Anavex Life Sciences (AVXL) United States $0.329B 0.00
Precigen (PGEN) United States $0.328B 0.00
Nkarta (NKTX) United States $0.324B 0.00
Nautilus Biotechnology (NAUT) United States $0.323B 0.00
Tenaya Therapeutics (TNYA) United States $0.322B 0.00
MeiraGTx Holdings (MGTX) United States $0.322B 0.00
Agenus (AGEN) United States $0.316B 0.00
Urogen Pharma (URGN) United States $0.311B 0.00
Replimune (REPL) United States $0.308B 0.00
Adlai Nortye (ANL) Cayman Islands $0.305B 0.00
Kamada (KMDA) Israel $0.298B 22.57
Atea Pharmaceuticals (AVIR) United States $0.297B 0.00
23andMe Holding (ME) United States $0.294B 0.00
Revance Therapeutics (RVNC) United States $0.292B 0.00
Solid Biosciences (SLDB) United States $0.290B 0.00
CorMedix Inc (CRMD) United States $0.289B 0.00
XOMA (XOMA) United States $0.288B 0.00
Mersana Therapeutics (MRSN) United States $0.288B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.286B 0.00
Poseida Therapeutics (PSTX) United States $0.279B 0.00
Inozyme Pharma (INZY) United States $0.279B 0.00
ADC Therapeutics SA (ADCT) Switzerland $0.276B 0.00
Candel Therapeutics (CADL) United States $0.261B 0.00
Inovio Pharmaceuticals (INO) United States $0.260B 0.00
Caribou Biosciences (CRBU) United States $0.260B 0.00
GENFIT S.A (GNFT) France $0.259B 0.00
Rani Therapeutics Holdings (RANI) United States $0.252B 0.00
Orchestra BioMed Holdings (OBIO) United States $0.251B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.249B 0.00
Prima BioMed (IMMP) Australia $0.246B 0.00
Emergent Biosolutions (EBS) United States $0.243B 0.00
UniQure (QURE) Netherlands $0.226B 0.00
Innate Pharma S.A (IPHA) France $0.226B 0.00
Codexis (CDXS) United States $0.225B 0.00
XBiotech (XBIT) United States $0.224B 0.00
Zura Bio (ZURA) United States $0.221B 0.00
Werewolf Therapeutics (HOWL) United States $0.221B 0.00
Design Therapeutics (DSGN) United States $0.218B 0.00
2seventy Bio (TSVT) United States $0.217B 0.00
Elevation Oncology (ELEV) United States $0.217B 0.00
Renovaro (RENB) United States $0.217B 0.00
ChromaDex (CDXC) United States $0.217B 0.00
Ovid Therapeutics (OVID) United States $0.213B 0.00
Coherus BioSciences (CHRS) United States $0.211B 0.00
Scilex Holding (SCLX) United States $0.207B 0.00
Compugen (CGEN) Israel $0.206B 0.00
Compass Therapeutics (CMPX) United States $0.202B 0.00
Monte Rosa Therapeutics (GLUE) United States $0.202B 0.00
Invivyd (IVVD) United States $0.200B 0.00
Boundless Bio (BOLD) United States $0.194B 0.00
Inventiva S.A (IVA) France $0.192B 0.00
INmune Bio (INMB) United States $0.191B 0.00
Puma Biotechnology (PBYI) United States $0.187B 11.76
Acumen Pharmaceuticals (ABOS) United States $0.183B 0.00
Trevi Therapeutics (TRVI) United States $0.179B 0.00
Opthea (OPT) Australia $0.175B 0.00
G1 Therapeutics (GTHX) United States $0.175B 0.00
Lifecore Biomedical (LFCR) United States $0.173B 0.00
Greenwich LifeSciences (GLSI) United States $0.170B 0.00
Abeona Therapeutics (ABEO) United States $0.167B 0.00
Oncobiologics (OTLK) United States $0.167B 0.00
Adverum Biotechnologies (ADVM) United States $0.166B 0.00
Sagimet Biosciences (SGMT) United States $0.166B 0.00
Rezolute (RZLT) United States $0.166B 0.00
Alimera Sciences (ALIM) United States $0.165B 0.00
X4 Pharmaceuticals (XFOR) United States $0.157B 0.00
Cartesian Therapeutics (RNAC) United States $0.155B 0.00
Kodiak Sciences (KOD) United States $0.155B 0.00
Molecular Partners AG (MOLN) Switzerland $0.154B 0.00
Cellectis S.A (CLLS) France $0.151B 0.00
ProQR Therapeutics (PRQR) Netherlands $0.149B 0.00
TELA Bio (TELA) United States $0.144B 0.00
I-Mab (IMAB) China $0.143B 0.00
Cardiff Oncology (CRDF) United States $0.143B 0.00
ScPharmaceuticals (SCPH) United States $0.141B 0.00
Seres Therapeutics (MCRB) United States $0.140B 0.00
Rapt Therapeutics (RAPT) United States $0.138B 0.00
Repare Therapeutics (RPTX) Canada $0.137B 0.00
BioStem Technologies (BSEM) $0.137B 0.00
CytomX Therapeutics (CTMX) United States $0.136B 8.75
Syros Pharmaceuticals (SYRS) United States $0.135B 0.00
Gossamer Bio (GOSS) United States $0.132B 0.00
Corvus Pharmaceuticals (CRVS) United States $0.131B 0.00
CervoMed (CRVO) United States $0.122B 0.00
Adicet Bio (ACET) United States $0.119B 0.00
Sangamo Therapeutics (SGMO) United States $0.119B 0.00
Nuvectis Pharma (NVCT) United States $0.118B 0.00
Seer (SEER) United States $0.117B 0.00
Adagene (ADAG) China $0.117B 0.00
ATyr Pharma (LIFE) United States $0.116B 0.00
Allakos (ALLK) United States $0.112B 0.00
Vigil Neuroscience (VIGL) United States $0.112B 0.00
Akoya Biosciences (AKYA) United States $0.112B 0.00
DBV Technologies S.A (DBVT) France $0.111B 0.00
Immunic (IMUX) United States $0.111B 0.00
Omega Therapeutics (OMGA) United States $0.109B 0.00
PDS Biotechnology (PDSB) United States $0.109B 0.00
Coya Therapeutics (COYA) United States $0.108B 0.00
BeyondSpring (BYSI) United States $0.108B 0.00
VistaGen Therapeutics (VTGN) United States $0.107B 0.00
DiaMedica Therapeutics (DMAC) United States $0.105B 0.00
BioHarvest Sciences (CNVCF) Canada $0.103B 0.00
Verastem (VSTM) United States $0.101B 0.00
Clearside Biomedical (CLSD) United States $0.101B 0.00
Bluebird Bio (BLUE) United States $0.099B 0.00
Athira Pharma (ATHA) United States $0.098B 0.00
Tiziana Life Sciences (TLSA) United Kingdom $0.097B 0.00
Vor Biopharma (VOR) $0.096B 0.00
Eton Pharmaceuticals (ETON) United States $0.095B 92.50
Connect Biopharma Holdings (CNTB) United States $0.088B 0.00
InflaRx (IFRX) Germany $0.086B 0.00
Precision BioSciences (DTIL) United States $0.085B 0.00
Gritstone Bio (GRTS) United States $0.084B 0.00
Milestone Pharmaceuticals (MIST) Canada $0.083B 0.00
Oncolytics Biotech (ONCY) Canada $0.083B 0.00
Cognition Therapeutics (CGTX) United States $0.082B 0.00
Barinthus Biotherapeutics (BRNS) United Kingdom $0.082B 0.00
IO Biotech (IOBT) Denmark $0.081B 0.00
Ikena Oncology (IKNA) United States $0.081B 0.00
Elutia (ELUT) United States $0.081B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.079B 0.00
Elicio Therapeutics (ELTX) United States $0.078B 0.00
Galena Biopharma (SLS) United States $0.078B 0.00
Cue Biopharma (CUE) United States $0.077B 0.00
Spero Therapeutics (SPRO) United States $0.077B 2.78
Eupraxia Pharmaceuticals (EPRX) Canada $0.076B 0.00
Genelux (GNLX) United States $0.076B 0.00
Provectus Biopharmaceuticals (PVCT) United States $0.076B 0.00
HOOKIPA Pharma (HOOK) United States $0.074B 0.00
Passage Bio (PASG) United States $0.073B 0.00
BioAtla (BCAB) United States $0.073B 0.00
VTv Therapeutics (VTVT) United States $0.071B 0.00
Alpha Teknova (TKNO) United States $0.071B 0.00
Aileron Therapeutics (ALRN) United States $0.071B 0.00
Benitec Biopharma (BNTC) United States $0.071B 0.00
Entera Bio (ENTX) Israel $0.070B 0.00
Instil Bio (TIL) United States $0.069B 0.00
Atara Biotherapeutics (ATRA) United States $0.067B 0.00
BioXcel Therapeutics (BTAI) United States $0.067B 0.00
Annovis Bio (ANVS) United States $0.067B 0.00
Intensity Therapeutics (INTS) United States $0.066B 0.00
MediciNova (MNOV) United States $0.066B 0.00
AVROBIO (AVRO) United States $0.066B 0.00
Bionano Genomics (BNGO) United States $0.066B 0.00
Checkpoint Therapeutics (CKPT) United States $0.065B 0.00
CollPlant Biotechnologies (CLGN) Israel $0.065B 0.00
Lantern Pharma (LTRN) United States $0.065B 0.00
Enzo Biochem (ENZ) United States $0.064B 0.00
Genenta Science S.p.A (GNTA) Italy $0.064B 0.00
Dyadic (DYAI) United States $0.063B 0.00
Curis (CRIS) United States $0.062B 0.00
AN2 Therapeutics (ANTX) United States $0.062B 0.00
Affimed (AFMD) Germany $0.061B 0.00
Regencell Bioscience Holdings (RGC) Hong Kong, SAR China $0.061B 0.00
Rallybio (RLYB) United States $0.061B 0.00
Turnstone Biologics (TSBX) United States $0.061B 0.00
Eledon Pharmaceuticals (ELDN) United States $0.060B 0.00
Earth Science Tech (ETST) United States $0.059B 0.00
CalciMedica (CALC) United States $0.059B 0.00
Theratechnologies (THTX) Canada $0.058B 0.00
Celularity (CELU) United States $0.058B 0.00
Immix Biopharma (IMMX) United States $0.058B 0.00
LENZ Therapeutics (LENZ) United States $0.057B 0.00
Leap Therapeutics (LPTX) United States $0.055B 0.00
Carmell (CTCX) United States $0.055B 0.00
Cidara Therapeutics (CDTX) United States $0.054B 0.00
Anebulo Pharmaceuticals (ANEB) United States $0.053B 0.00
Prenetics Global (PRE) Hong Kong, SAR China $0.053B 0.00
Kezar Life Sciences (KZR) United States $0.050B 0.00
ARCA Biopharma (ABIO) United States $0.050B 0.00
Lexaria Bioscience (LEXX) Canada $0.049B 0.00
Equillium (EQ) United States $0.049B 0.00
Ocean Biomedical (OCEA) United States $0.048B 0.00
Kronos Bio (KRON) United States $0.048B 0.00
Aligos Therapeutics (ALGS) United States $0.048B 0.00
Dare Bioscience (DARE) United States $0.048B 0.00
Clene (CLNN) United States $0.047B 0.00
NextCure (NXTC) United States $0.045B 0.00
IN8bio (INAB) United States $0.045B 0.00
Ocuphire Pharma (OCUP) United States $0.044B 0.00
Beyond Air (XAIR) United States $0.043B 0.00
Aadi Bioscience (AADI) United States $0.043B 0.00
Immuneering (IMRX) United States $0.043B 0.00
HCW Biologics (HCWB) United States $0.042B 0.00
OKYO Pharma (OKYO) $0.042B 0.00
NKGen Biotech (NKGN) United States $0.041B 0.00
Eyenovia (EYEN) United States $0.040B 0.00
Acurx Pharmaceuticals (ACXP) United States $0.040B 0.00
Quince Therapeutics (QNCX) United States $0.037B 0.00
Brainstorm Cell Therapeutics (BCLI) United States $0.037B 0.00
Achilles Therapeutics (ACHL) United Kingdom $0.037B 0.00
Cyclo Therapeutics (CYTH) United States $0.037B 0.00
Estrella Immunopharma (ESLA) United States $0.037B 0.00
Fortress Biotech (FBIO) United States $0.036B 0.00
Xilio Therapeutics (XLO) United States $0.035B 0.00
Cara Therapeutics (CARA) United States $0.034B 0.00
MiNK Therapeutics (INKT) United States $0.034B 0.00
Promis Neurosciences (PMN) Canada $0.033B 0.00
Evogene (EVGN) Israel $0.032B 0.00
Pluri (PLUR) Israel $0.032B 0.00
RenovoRx (RNXT) United States $0.029B 0.00
Bolt Biotherapeutics (BOLT) United States $0.029B 0.00
Spruce Biosciences (SPRB) United States $0.029B 0.00
BioAffinity Technologies (BIAF) United States $0.029B 0.00
Apollomics (APLM) United States $0.027B 0.00
UNITY Biotechnology (UBX) United States $0.026B 0.00
Lisata Therapeutics (LSTA) United States $0.026B 0.00
SAB Biotherapeutics (SABS) United States $0.026B 0.00
Femasys (FEMY) United States $0.026B 0.00
Aprea Therapeutics (APRE) United States $0.025B 0.00
BRIACELL THERAP (BCTX) Canada $0.025B 0.00
Cocrystal Pharma (COCP) United States $0.023B 0.00
Forte Biosciences (FBRX) United States $0.022B 0.00
CytoMed Therapeutics (GDTC) Singapore $0.022B 0.00
Sensei Biotherapeutics (SNSE) United States $0.021B 0.00
Biora Therapeutics (BIOR) United States $0.021B 0.00
Purple Biotech (PPBT) Israel $0.020B 0.00
NeuroBo Pharmaceuticals (NRBO) United States $0.020B 0.00
Vincerx Pharma (VINC) United States $0.019B 0.00
Evaxion Biotech (EVAX) Denmark $0.019B 0.00
Synlogic (SYBX) United States $0.019B 0.00
Lumos Pharma (LUMO) United States $0.019B 0.00
Aptose Biosciences (APTO) Canada $0.019B 0.00
KALA BIO (KALA) United States $0.018B 0.00
Orgenesis (ORGS) United States $0.017B 0.00
VBI Vaccines (VBIV) United States $0.017B 0.00
Aytu BioPharma (AYTU) United States $0.017B 0.00
Talis Biomedical (TLIS) United States $0.017B 0.00
Galecto (GLTO) Denmark $0.016B 0.00
Cardio Diagnostics Holdings (CDIO) United States $0.016B 0.00
NeuroSense Therapeutics (NRSN) Israel $0.015B 0.00
Senti Biosciences (SNTI) United States $0.015B 0.00
Kintara Therapeutics (KTRA) United States $0.015B 0.00
Akari Therapeutics (AKTX) United Kingdom $0.014B 0.00
Imunon (IMNN) United States $0.014B 0.00
Edesa Biotech (EDSA) Canada $0.013B 0.00
IMMURON (IMRN) Australia $0.013B 0.00
MIRA Pharmaceuticals (MIRA) United States $0.013B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.013B 0.00
Semper Paratus Acquisition (TVGN) United States $0.013B 0.00
Elevai Labs (ELAB) United States $0.013B 0.00
AEterna Zentaris (AEZS) Canada $0.012B 0.00
Monopar Therapeutics (MNPR) United States $0.011B 0.00
Galera Therapeutics (GRTX) United States $0.011B 0.00
Chemomab Therapeutics (CMMB) Israel $0.011B 0.00
Moleculin Biotech (MBRX) United States $0.010B 0.00
Eterna Therapeutics (ERNA) United States $0.010B 0.00
Organovo Holdings (ONVO) United States $0.010B 0.00
Coeptis Therapeutics Holdings (COEP) United States $0.010B 0.00
ABVC BioPharma (ABVC) United States $0.010B 0.00
BioCardia (BCDA) United States $0.009B 0.00
NuCana (NCNA) United Kingdom $0.009B 0.00
Prana Biotechnology (ATHE) Australia $0.009B 0.00
Biorestorative Therapies (BRTX) United States $0.009B 0.00
Genetic Technologies (GENE) Australia $0.008B 0.00
Vaccinex (VCNX) United States $0.008B 0.00
Bionomics (BNOX) Australia $0.008B 0.00
EFFECTOR Therapeutics (EFTR) United States $0.008B 0.00
Cyclerion Therapeutics (CYCN) United States $0.007B 0.00
Trevena (TRVN) United States $0.007B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.007B 0.00
AquaBounty Technologies (AQB) United States $0.007B 0.00
Tenax Therapeutics (TENX) United States $0.007B 0.00
Pulmatrix (PULM) United States $0.007B 0.00
Cadrenal Therapeutics (CVKD) United States $0.007B 0.00
Longeveron (LGVN) United States $0.007B 0.00
Onconetix (ONCO) United States $0.007B 0.00
Hepion Pharmaceuticals (HEPA) United States $0.007B 0.00
Atrinsic (PTIX) United States $0.007B 0.00
Psyence Biomedical (PBM) United States $0.006B 0.00
Entero Therapeutics (ENTO) United States $0.006B 0.00
TFF Pharmaceuticals (TFFP) United States $0.006B 0.00
Telesis Bio (TBIO) United States $0.006B 0.00
Pasithea Therapeutics (KTTA) United States $0.006B 0.00
Enveric Biosciences (ENVB) United States $0.006B 0.00
Kineta (KA) United States $0.006B 0.00
Creative Medical Technology Holdings (CELZ) United States $0.006B 0.00
Titan Pharmaceuticals (TTNP) United States $0.006B 0.00
Hoth Therapeutics (HOTH) United States $0.006B 0.00
Biofrontera (BFRI) United States $0.006B 0.00
Soligenix (SNGX) United States $0.006B 0.00
Synaptogenix (SNPX) United States $0.005B 0.00
Silo Pharma (SILO) United States $0.005B 0.00
Sonnet BioTherapeutics Holdings (SONN) United States $0.005B 0.00
Lixte Biotechnology Holdings (LIXT) United States $0.005B 0.00
Bright Minds Biosciences (DRUG) United States $0.005B 0.00
Adial Pharmaceuticals (ADIL) United States $0.005B 0.00
GT Biopharma (GTBP) United States $0.005B 0.00
GENPREX (GNPX) United States $0.005B 0.00
Lipella Pharmaceuticals (LIPO) United States $0.005B 0.00
Portage Biotech (PRTG) $0.005B 0.00
Ensysce Biosciences (ENSC) United States $0.005B 0.00
ThermoGenesis Holdings (THMO) United States $0.005B 0.00
Artelo Biosciences (ARTL) United States $0.005B 0.00
NexImmune (NEXI) United States $0.004B 0.00
Virios Therapeutics (VIRI) United States $0.004B 0.00
Cingulate (CING) United States $0.004B 0.00
Palisade Bio (PALI) United States $0.004B 0.00
GeoVax Labs (GOVX) United States $0.004B 0.00
TRACON Pharmaceuticals (TCON) United States $0.004B 0.44
Alzamend Neuro (ALZN) United States $0.004B 0.00
Novogen (KZIA) Australia $0.004B 0.00
Tharimmune (THAR) United States $0.004B 0.00
ZyVersa Therapeutics (ZVSA) United States $0.004B 0.00
Exicure (XCUR) United States $0.003B 0.19
TC BioPharm (Holdings) (TCBP) United Kingdom $0.003B 0.00
Invo BioScience (INVO) United States $0.003B 0.00
Avalon GloboCare (ALBT) United States $0.003B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.003B 0.00
Aptevo Therapeutics (APVO) United States $0.003B 0.00
Mustang Bio (MBIO) United States $0.003B 0.00
Seelos Therapeutics (SEEL) United States $0.003B 0.00
Revelation Biosciences (REVB) United States $0.003B 0.00
CNS Pharmaceuticals (CNSP) United States $0.003B 0.00
Windtree Therapeutics (WINT) United States $0.002B 0.00
Notable Labs (NTBL) United States $0.002B 0.00
Bone Biologics (BBLG) United States $0.002B 0.00
Dermata Therapeutics (DRMA) United States $0.002B 0.00
180 Life Sciences (ATNF) United States $0.001B 0.00
Virax Biolabs Group (VRAX) United Kingdom $0.001B 0.00
NeuBase Therapeutics (NBSE) United States $0.001B 0.00
Allarity Therapeutics (ALLR) United States $0.001B 0.00
Biodexa Pharmaceuticals (BDRX) United Kingdom $0.001B 0.00
GRI Bio (GRI) United States $0.001B 0.00
Virpax Pharmaceuticals (VRPX) United States $0.001B 0.00
Scinai Immunotherapeutics (SCNI) Israel $0.001B 0.00
Sunshine Biopharma (SBFM) United States $0.001B 0.00
Aceragen (ACGN) United States $0.000B 0.00
Alvotech (ALVO) $0.000B 0.00
ARAVIVE, INC (ARAV) United States $0.000B 0.00
Celyad SA (CYAD) Belgium $0.000B 0.00
LAVA Therapeutics (LVTX) Netherlands $0.000B 0.00
Motif Bio Plc (MTFB) United Kingdom $0.000B 0.00
Mainz Biomed (MYNZ) Germany $0.000B 0.00
PDL BioPharma (PDLI) United States $0.000B 0.00
Pharvaris (PHVS) Netherlands $0.000B 0.00
VectivBio Holding AG (VECT) Switzerland $0.000B 0.00
Clovis Oncology (CLVSQ) United States $0.000B 0.00